Related Experiment Video
Updated: Jun 12, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Research Progress on Ferroptosis in Multiple Myeloma
Po Li1, Tianxin Lyu2
1Department of Orthopedic, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.
Opinion Statement:
Multiple myeloma (MM) is the second most common hematological malignant (HM) tumor, and a large proportion of patients still suffer from treatment failure and a poor prognosis despite the use of some newly approved drugs, a deeper understanding of the underlying mechanism is still needed. Ferroptosis is a new form of programmed cell death (PCD) that is different from other traditional forms of cell death such as apoptosis, necrosis and autophagy. With the continuous deepening of research on ferroptosis, ferroptosis has been found to be closely related to MM. This article reviews the regulatory mechanism of ferroptosis and research progress on ferroptosis in MM, providing a new theoretical basis and strategies for the diagnosis and treatment of MM.
Insights
Multiple myeloma (MM) treatment needs new strategies. Ferroptosis, a distinct cell death type, is increasingly linked to MM, offering potential new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Multiple myeloma (MM) is a common hematological malignancy with significant treatment challenges.
- Despite advancements, many patients experience treatment failure and poor prognosis.
- A deeper understanding of MM's underlying mechanisms is crucial for therapeutic innovation.
Purpose of the Study:
- To review the regulatory mechanisms of ferroptosis.
- To summarize the research progress on ferroptosis in the context of multiple myeloma.
- To provide a theoretical basis for novel MM diagnosis and treatment strategies.
Main Methods:
- Literature review of ferroptosis and multiple myeloma research.
- Analysis of the relationship between ferroptosis and MM pathogenesis.
- Synthesis of current understanding of ferroptosis regulatory pathways.
Main Results:
- Ferroptosis is a distinct form of programmed cell death (PCD) differing from apoptosis, necrosis, and autophagy.
- Emerging evidence highlights a significant association between ferroptosis and multiple myeloma.
- Understanding ferroptosis offers new insights into MM development and progression.
Conclusions:
- Ferroptosis represents a promising area for developing novel therapeutic strategies for multiple myeloma.
- Targeting ferroptosis could overcome current treatment limitations in MM.
- Further research into ferroptosis mechanisms in MM is warranted for clinical application.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
